MX2022011245A - Método de generación de células hepáticas. - Google Patents

Método de generación de células hepáticas.

Info

Publication number
MX2022011245A
MX2022011245A MX2022011245A MX2022011245A MX2022011245A MX 2022011245 A MX2022011245 A MX 2022011245A MX 2022011245 A MX2022011245 A MX 2022011245A MX 2022011245 A MX2022011245 A MX 2022011245A MX 2022011245 A MX2022011245 A MX 2022011245A
Authority
MX
Mexico
Prior art keywords
hepatic cells
generating
generating hepatic
methods
cells
Prior art date
Application number
MX2022011245A
Other languages
English (en)
Inventor
Tüzer Kalkan
Thomas Pierre Michel Moreau
Carl Ward
Tildon Grant Belgard
Fabian Bachinger
Original Assignee
Bit Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bit Bio Ltd filed Critical Bit Bio Ltd
Priority claimed from PCT/GB2021/050622 external-priority patent/WO2021181110A1/en
Publication of MX2022011245A publication Critical patent/MX2022011245A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)

Abstract

La invención se refiere a métodos de generación de células hepáticas mediante la sobre-expresión de combinaciones de factores de transcripción, en particular para usarse en métodos de reprogramación celular.
MX2022011245A 2020-03-11 2021-03-11 Método de generación de células hepáticas. MX2022011245A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062988349P 2020-03-11 2020-03-11
PCT/GB2021/050622 WO2021181110A1 (en) 2020-03-11 2021-03-11 Method of generating hepatic cells

Publications (1)

Publication Number Publication Date
MX2022011245A true MX2022011245A (es) 2023-01-11

Family

ID=77663668

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022011245A MX2022011245A (es) 2020-03-11 2021-03-11 Método de generación de células hepáticas.

Country Status (9)

Country Link
US (2) US11274279B2 (es)
EP (1) EP4118188A1 (es)
JP (1) JP2023516484A (es)
KR (1) KR20230010625A (es)
CN (1) CN115551994A (es)
AU (1) AU2021235252A1 (es)
BR (1) BR112022018092A2 (es)
CA (1) CA3175071A1 (es)
MX (1) MX2022011245A (es)

Family Cites Families (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837234A (en) 1995-06-07 1998-11-17 Cytotherapeutics, Inc. Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
NZ337792A (en) 1999-09-14 2002-03-28 Pastoral Agric Res Inst Nz Ltd Nuclear transfer and use in cloning
US20030082155A1 (en) 1999-12-06 2003-05-01 Habener Joel F. Stem cells of the islets of langerhans and their use in treating diabetes mellitus
US7544509B2 (en) 2000-01-24 2009-06-09 Mcgill University Method for preparing stem cell preparations
AU2001236919A1 (en) 2000-02-09 2001-08-20 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Premeiotic and postmeiotic origin of teratomas: isolated teratoma stem cells for therapeutic uses
US7473555B2 (en) 2000-04-27 2009-01-06 Geron Corporation Protocols for making hepatocytes from embryonic stem cells
JP2004529621A (ja) 2001-02-14 2004-09-30 ティー ファークト，レオ 多能性成体幹細胞、その起源、それを得る方法および維持する方法、それを分化させる方法、その使用法、ならびにそれ由来の細胞
WO2002073188A1 (en) 2001-03-13 2002-09-19 Advanced Cell Technology, Inc. Method for generating replacement cells and/or tissues
US6582955B2 (en) 2001-05-11 2003-06-24 Spectrum Laboratories, Inc. Bioreactor with application as blood therapy device
WO2003004627A2 (fr) 2001-07-06 2003-01-16 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M.) Lignees d'hepatomes humains leurs optentions et leurs applications
WO2003023019A1 (en) 2001-09-07 2003-03-20 Fox Chase Cancer Center Methods and cell cultures for promoting organogenesis and tissue development
EP1442115B9 (en) 2001-11-15 2009-12-16 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
TWI288779B (en) 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
AUPS187202A0 (en) 2002-04-22 2002-05-30 Griffith University Method for culturing stem cells
WO2004007683A2 (en) 2002-07-15 2004-01-22 Massachusetts Institute Of Technology Cellular reprogramming in peptide hydrogel and uses thereof
WO2004046310A2 (en) 2002-11-15 2004-06-03 Five Prime Therapeutics, Inc. Novel mouse polypeptides encoded by polynucleotides and methods of their use
WO2005005621A2 (en) 2003-07-08 2005-01-20 Axiogenesis Ag NOVEL METHOD FOR THE PREPARATION OF EMBRYOID BODIES (EBs) AND USES THEREOF
US20070134796A1 (en) 2005-07-26 2007-06-14 Sangamo Biosciences, Inc. Targeted integration and expression of exogenous nucleic acid sequences
EP1516924A1 (en) 2003-09-17 2005-03-23 Fundacion IVI para el Estudio de la reproduccion Humana (FIVIER) Generation of human embryonic stem cells from triploid zygotes
EP1516925A1 (en) 2003-09-18 2005-03-23 Fundacion IVI para el Estudio de la reproduccion Humana (FIVIER) Generation of human embryonic stem cells from triploid zygotes
WO2005040391A1 (en) 2003-10-27 2005-05-06 Murdoch Childrens Research Institute Compositions and methods for differentiating stem cells
CN1871343B (zh) 2003-11-04 2013-06-26 株式会社宝玛斯特 从脂肪组织制备干细胞的方法和系统
GB0329449D0 (en) 2003-12-19 2004-01-28 Omnicyte Ltd Stem cells
US20060040386A1 (en) 2004-01-14 2006-02-23 Suchitra Holgersson Human hepatic progenitor cells and methods of use thereof
EP1576957A1 (en) 2004-03-18 2005-09-21 Universiteit Twente Tissue repair using pluripotent cells
WO2005097980A2 (en) 2004-03-26 2005-10-20 Geron Corporation New protocols for making hepatocytes from embryonic stem cells
EP1600500A1 (en) 2004-05-27 2005-11-30 Georg-August-Universität Göttingen Method for producing pluripotent cells from monocytes
KR20060089774A (ko) 2005-02-04 2006-08-09 재단법인서울대학교산학협력재단 서로 다른 개체로부터 유래된 체세포와 난자로부터 유래된 인간 배아 줄기세포 및 그 제조방법
WO2006126219A1 (en) 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
WO2006131543A1 (en) 2005-06-09 2006-12-14 Artemis Pharmaceuticals Gmbh Shrna and sirna expression in a living organism under control op a codon-optimized tetracycline repressor gene
WO2007002228A1 (en) 2005-06-23 2007-01-04 Massachusetts Institute Of Technology Methods for ex vivo propagation of adult hepatic stem cells
US8048999B2 (en) 2005-12-13 2011-11-01 Kyoto University Nuclear reprogramming factor
DK2281875T3 (en) 2005-12-21 2018-06-06 Univ Catholique Louvain Isolated liver stem cells
US8148151B2 (en) 2006-06-02 2012-04-03 Geron Corporation Differentiation of primate pluripotent cells to hepatocyte-lineage cells
ITMI20061772A1 (it) 2006-09-18 2008-03-19 Consiglio Nazionale Ricerche Procedimento per la preparazione di cellule epatiche da cellule progenitrici presenti nel sangue di cordone ombelicale
WO2008060792A2 (en) 2006-10-12 2008-05-22 Stem Cells Innovations Novel cells, compositions, and methods
US8835163B2 (en) 2006-10-18 2014-09-16 The Board Of Trustees Of The University Of Illinois Embryonic-like stem cells derived from adult human peripheral blood and methods of use
AU2008205459A1 (en) 2007-01-19 2008-07-24 Mount Sinai School Of Medicine Of New York University Stem cell gene targeting
EP2607477B1 (en) 2007-05-03 2020-09-23 The Brigham and Women's Hospital, Inc. Multipotent stem cells and uses thereof
JP5124820B2 (ja) 2007-05-30 2013-01-23 国立大学法人 熊本大学 Ｅｓ細胞の分化誘導方法
WO2008153180A1 (ja) 2007-06-14 2008-12-18 Akifumi Matsuyama 脂肪組織由来細胞から肝小葉様細胞塊を得る方法
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
GB2450761B (en) 2007-07-06 2010-08-04 Univ London Multi-functional chamber for housing a biological component
WO2009080794A1 (en) 2007-12-21 2009-07-02 Mc2 Cell Aps Method for preparing cell-specific extracellular matrices
WO2010007031A2 (en) 2008-07-14 2010-01-21 Novartis Ag Methods for improving cardiac differentiation of human embryonic stem cells
WO2010049752A1 (en) 2008-10-31 2010-05-06 Katholieke Universiteit Leuven Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
DK2356213T3 (da) 2008-11-04 2019-09-09 Viacyte Inc Stamcelleaggregatsuspensionssammensætninger og fremgangsmåder til differentiering deraf
EP2367931B1 (en) 2008-12-03 2017-05-31 International Stem Cell Corporation Methods of deriving differentiated cells from stem cells
CN101748096B (zh) 2008-12-17 2013-03-13 北京汉氏联合生物技术有限公司 亚全能干细胞、其制备方法及其用途
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
GB0905331D0 (en) 2009-03-27 2009-05-13 Avecia Biolog Ltd Expression process
WO2010117464A1 (en) 2009-04-09 2010-10-14 Sangamo Biosciences, Inc. Targeted integration into stem cells
EP2421954B1 (en) 2009-04-21 2018-12-26 Academisch Ziekenhuis bij de Universiteit van Amsterdam Differentiated human liver cell cultures and their use in bioartificial liver systems
EP2253700A1 (en) 2009-05-13 2010-11-24 Helmholtz-Zentrum für Infektionsforschung GmbH A method for producing test systems from donors suffering from adverse effects of medicaments and /or medical treatments, and uses of said systems
US10913929B2 (en) 2009-10-13 2021-02-09 Stemcell Technologies Inc. Method of differentiating stem cells
JP5745423B2 (ja) 2009-10-28 2015-07-08 公益財団法人ヒューマンサイエンス振興財団 幹細胞から肝細胞への分化誘導方法
WO2011084747A2 (en) 2009-12-21 2011-07-14 The Johns Hopkins University Compositions and methods for somatic tissue induced pluripotent stem cells having an endoderm origin
EP2550355B1 (en) 2010-03-22 2016-11-16 Takara Bio Europe AB Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of wnt-signalling pathway
SG184204A1 (en) 2010-03-23 2012-10-30 Kuraray Co Culture method for causing differentiation of pluripotent mammalian cells
WO2011119942A1 (en) 2010-03-25 2011-09-29 Vistagen Therapeutics, Inc. Induction of ips cells using transient episomal vectors
JP5968871B2 (ja) 2010-04-13 2016-08-10 セルラー ダイナミクス インターナショナル， インコーポレイテッド フォワードプログラミングによる肝細胞の産生
EP2588592B1 (en) 2010-06-30 2017-09-06 Miromatrix Medical Inc. Use of perfusion decellularized organs for matched recellularization
WO2012005690A1 (en) 2010-07-07 2012-01-12 Massachusetts Institute Of Technology Methods of reconstituting human hepatocytes and human hematopoietic cells in non-human mammals
US8765470B2 (en) 2010-08-04 2014-07-01 Cellular Dynamics International, Inc. Reprogramming immortalized B-cells to induced pluripotent stem cells
GB201014169D0 (en) 2010-08-25 2010-10-06 Cambridge Entpr Ltd In vitro hepatic differentiation
US9181529B2 (en) 2010-10-19 2015-11-10 Cellular Dynamics International, Inc. Titration of differentiation medium components
JP5938726B2 (ja) 2010-10-28 2016-06-22 国立大学法人 熊本大学 多能性幹細胞の分化誘導効率を改善するための方法及び培地
US9555061B2 (en) 2011-04-15 2017-01-31 National University Corporation Torrori University Synthesis and analysis of compounds capable of inducing differentiation of human mesenchymal stems cells into hepatocytes
US20140134195A1 (en) 2011-04-20 2014-05-15 University Of Washington Through Its Center For Commercialization Beta-2 microglobulin-deficient cells
WO2013062140A1 (en) 2011-10-28 2013-05-02 Kyoto University Method for efficiently inducing differentiation of pluripotent stem cells into hepatic lineage cells
GB201119335D0 (en) 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
US20130212722A1 (en) 2012-02-15 2013-08-15 Mice With Horns, Llc Transgenic animals with customizable traits
AU2013246040B2 (en) 2012-04-09 2018-11-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for generation of pluripotent and multipotent cells
AU2012202353B2 (en) 2012-04-20 2015-01-15 Medela Holding Ag Stem cell preparations and methods of use
WO2013189521A1 (en) 2012-06-19 2013-12-27 Waclawczyk Simon Method of generating cells of hepatocyte phenotype
GB201212111D0 (en) 2012-07-06 2012-08-22 Gmbh Vascular bed-specific endothelial cells
WO2014053709A1 (en) 2012-10-05 2014-04-10 Glykos Finland Oy A method for culturing stem cells
CN105143445B (zh) 2012-11-29 2020-07-07 宝生物欧洲公司 衍生自人多能干细胞的肝细胞样细胞的成熟
CN103981147B (zh) 2013-02-08 2017-11-10 中国科学院上海生命科学研究院 一种新的制备肝实质细胞的方法
US10913933B2 (en) 2013-02-13 2021-02-09 Wake Forest University Health Sciences Bioengineered liver constructs and methods relating thereto
CA2900690A1 (en) 2013-03-15 2014-09-18 F. Hoffmann-La Roche Ag Compounds for improved stem cell differentiation into hepatocytes
WO2014144125A1 (en) 2013-03-15 2014-09-18 The Broad Institute, Inc. Compounds for inducing proliferation and differentiation of cells, and methods of use thereof
WO2014153346A1 (en) 2013-03-18 2014-09-25 Massachusetts Institute Of Technology Engineering a heterogeneous tissue pluripotent stem cells
EP2980207B1 (en) 2013-03-25 2018-12-05 Foundation for Biomedical Research and Innovation at Kobe Cell sorting method
GB201307486D0 (en) 2013-04-25 2013-06-12 Cambridge Entpr Ltd Cell-cycle directed differentiation of pluripotent cells
DK3046628T3 (da) 2013-09-19 2020-02-10 Univ Leland Stanford Junior Fremgangsmåder og sammensætninger til fremstilling af hepatocyt-lignende celler
GB201317869D0 (en) 2013-10-09 2013-11-20 Cambridge Entpr Ltd In vitro production of foregut stem cells
KR101542849B1 (ko) 2013-11-01 2015-08-10 주식회사 비비에이치씨 중간엽 줄기세포로부터 유도된 만능 줄기세포를 이용하여 간세포로 분화시키는 방법
WO2015073751A1 (en) 2013-11-15 2015-05-21 Applied Stemcell, Inc. Methods for isolating lineage-specific cells
US10100284B2 (en) 2013-12-25 2018-10-16 Toagosei Co. Ltd. Method for inducing differentiation of pluripotent stem cells into endodermal cells
CA2936838A1 (en) 2014-01-14 2015-07-23 Colorado State University Research Foundation Stem cell-derived hepatocytes in co-culture and uses thereof
EP3097186B1 (en) 2014-01-21 2019-05-08 The Medical College of Wisconsin, Inc. Methods for selective inhibition of pluripotent stem cells
CN104830906B (zh) 2014-02-12 2018-09-04 北京维通达生物技术有限公司 一种重编程获得功能性人肝脏实质细胞的方法
US11066649B2 (en) 2014-03-19 2021-07-20 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for inducing human cholangiocyte differentiation
US20170107486A1 (en) 2014-04-21 2017-04-20 Cellular Dynamics International, Inc. Hepatocyte production via forward programming by combined genetic and chemical engineering
GB201409858D0 (en) 2014-06-03 2014-07-16 Ucl Business Plc Human liver scaffolds
KR101535070B1 (ko) 2014-07-16 2015-07-10 서울대학교산학협력단 혈관성장인자 유전자의 형질전환을 위한 재조합 발현 벡터 및 이를 이용한 혈관성장인자 발현 줄기세포주
CN107075467B (zh) 2014-09-19 2020-08-21 新加坡科技研究局 由干细胞分化肝细胞样细胞
JP2017534269A (ja) 2014-10-08 2017-11-24 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 幹細胞を肝臓細胞系譜に分化させる方法
JP5777127B1 (ja) 2014-12-09 2015-09-09 公立大学法人横浜市立大学 原始腸内胚葉細胞及びその作製方法
US10590389B2 (en) 2014-12-24 2020-03-17 Kyoto University Endodermal cell production method, liver cell production method, pancreatic cell production method, endodermal cell induction promoter, liver cell induction promoting kit, pancreatic cell induction promoting kit, and microfluidic device
WO2016104717A1 (ja) 2014-12-26 2016-06-30 国立大学法人京都大学 肝細胞誘導方法
US10836997B2 (en) 2015-03-09 2020-11-17 Keio University Method for differentiating pluripotent stem cells into desired cell type
EP3708652A3 (en) 2015-03-18 2020-12-16 The University of Tokyo Liver sinusoidal endothelial progenitor cells, and methods for preparation thereof
US20180072988A1 (en) 2015-04-10 2018-03-15 Agency For Science, Technology And Research Generation of functional cells from stem cells
AU2016261600B2 (en) 2015-05-08 2021-09-23 President And Fellows Of Harvard College Universal donor stem cells and related methods
JP6713691B2 (ja) 2015-08-20 2020-07-01 大学共同利用機関法人情報・システム研究機構 動物細胞ゲノム部位特異的外来ｄｎａ挿入方法及び前記挿入方法を用いて得られる細胞
EP3350313A4 (en) 2015-09-15 2019-06-12 Agency For Science, Technology And Research (A*star) DERIVATION OF HEPATIC ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS
WO2017047762A1 (ja) 2015-09-18 2017-03-23 国立大学法人鳥取大学 低分子化合物による癌と線維化の抑制と再生促進の効果
WO2017070145A1 (en) 2015-10-19 2017-04-27 Cellular Dynamics International, Inc. Production of virus-receptive pluripotent stem cell (psc)-derived hepatocytes
EP3384024B1 (en) 2015-12-01 2022-02-02 CRISPR Therapeutics AG Materials and methods for treatment of alpha-1 antitrypsin deficiency
GB201521179D0 (en) 2015-12-01 2016-01-13 Univ Leuven Kath Methods for differentiating cells into hepatic stellate cells
MX2018007840A (es) 2015-12-23 2019-05-02 Crispr Therapeutics Ag Materiales y metodos para el tratamiento de la esclerosis lateral amiotrofica y/o la degeneracion lobar frontotemporal.
JP6694512B2 (ja) 2015-12-30 2020-05-13 フジフィルム セルラー ダイナミクス，インコーポレイテッド 幹細胞由来ヒト肝細胞を使用した微小組織形成
JP6792857B2 (ja) 2016-01-29 2020-12-02 国立大学法人千葉大学 肝細胞系譜細胞を取得するための方法および物質
US11396644B2 (en) 2016-01-31 2022-07-26 Keio University Method for promoting differentiation of pluripotent stem cells by reducing undifferentiated state thereof
US20190112353A1 (en) 2016-02-18 2019-04-18 Crispr Therapeutics Ag Materials and methods for treatment of severe combined immunodeficiency (scid) or omenn syndrome
GB201603569D0 (en) 2016-03-01 2016-04-13 Koninklijke Nederlandse Akademie Van Wetenschappen Improved differentiation method
EP3429632B1 (en) 2016-03-16 2023-01-04 CRISPR Therapeutics AG Materials and methods for treatment of hereditary haemochromatosis
ITUA20162645A1 (it) 2016-04-15 2017-10-15 Ustem S R L Un nuovo metodo per la riprogrammazione cellulare
WO2018007871A1 (en) 2016-07-08 2018-01-11 Crispr Therapeutics Ag Materials and methods for treatment of transthyretin amyloidosis
WO2018025975A1 (ja) 2016-08-03 2018-02-08 株式会社生命科学インスティテュート インビトロで多能性幹細胞を分化誘導する方法
WO2018058026A1 (en) 2016-09-26 2018-03-29 Boston Scientific Scimed, Inc. Mitochondrial epigenetic reprogramming and transplant
EP3534976A4 (en) 2016-11-04 2020-09-16 Children's Hospital Medical Center LIVER ORGANOID DISEASE MODELS AND METHODS OF MANUFACTURING AND USING THEREOF
CN109983118B (zh) 2016-11-16 2024-04-16 美国绿阳生物技术及医药公司 以rna通过干细胞分化诱导肝细胞
GB201619876D0 (en) 2016-11-24 2017-01-11 Cambridge Entpr Ltd Controllable transcription
CN110582570A (zh) 2017-02-22 2019-12-17 克里斯珀医疗股份公司 用于治疗前蛋白转化酶枯草杆菌蛋白酶/Kexin 9型(PCSK9)相关的病症的组合物和方法
US11136555B2 (en) 2017-03-01 2021-10-05 Elixirgen Scientific, Inc. Compositions and methods for differentiation of human pluripotent stem cells into desired cell types
US20200140821A1 (en) 2017-06-07 2020-05-07 Wild Type, Inc. Ex vivo meat production
KR20240010095A (ko) 2017-06-09 2024-01-23 칠드런즈 호스피탈 메디칼 센터 간 유사 장기 조성물 및 이를 제조 및 사용하는 방법
EP3638772B1 (en) 2017-06-16 2024-08-28 Katholieke Universiteit Leuven Cell culture media for differentiation of stem cells into hepatocytes
US11530132B2 (en) 2017-09-05 2022-12-20 Lemonex Inc. Composition comprising porous silica particles carrying a cell fate modulating factor
JP2020533025A (ja) 2017-09-12 2020-11-19 ベス イスラエル デアコネス メディカル センター インコーポレイティッド 肝疾患および機能不全を処置するための組成物および方法
EP3702444A4 (en) 2017-10-12 2021-06-02 Tokyo Institute of Technology METHOD FOR INDUCING THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS IN HEPATOCYTE
EP3727394A4 (en) 2017-12-21 2021-09-08 Children's Hospital Medical Center DIGITIZED HUMAN ORGANOIDS AND METHODS OF USING THEM
US11946069B2 (en) 2018-03-12 2024-04-02 RxCell, Inc. Method for generating multiple cellular products from single pluripotent cell source
WO2019213366A1 (en) 2018-05-02 2019-11-07 The Trustees Of Columbia University In The City Of New York Methods to induce terminal differentiation in stem cells by interfering with dna replication, methods of inducing pancreatic differentiation, and differentiated cells obtained thereof
EP3793579A4 (en) 2018-05-16 2022-02-23 Washington University METHODS AND COMPOSITIONS FOR GENERATION OF ENDODERMAL LINEAGE AND BETA CELLS AND USES THEREOF
CA3101372A1 (en) 2018-05-25 2019-11-28 Valorisation-Hsj, Limited Partnership Process for making cell populations of the hepatic lineage from endodermal cells and cellular compositions comprising same
US20210254012A1 (en) 2018-06-09 2021-08-19 Arizona Board Of Regents On Behalf Of Arizona State University Next generation designer liver organoids and their methods of preparation and use
CA3103823A1 (en) 2018-06-14 2019-12-19 Figene, Llc Use of fibroblasts and/or modified fibroblasts for three dimensional tissue printing
JP2021535753A (ja) 2018-09-12 2021-12-23 チルドレンズ ホスピタル メディカル センター 造血幹細胞およびその派生体の生成のためのオルガノイド組成物
WO2020081716A2 (en) 2018-10-16 2020-04-23 Texas Tech University System Biomaterials for 3d cell growth and differentiation
TW202043459A (zh) 2018-12-26 2020-12-01 中央研究院 調節萬能性幹細胞之潛能的方法及應用

Also Published As

Publication number Publication date
EP4118188A1 (en) 2023-01-18
US20210284960A1 (en) 2021-09-16
US11274279B2 (en) 2022-03-15
KR20230010625A (ko) 2023-01-19
CA3175071A1 (en) 2021-09-16
BR112022018092A2 (pt) 2022-11-22
JP2023516484A (ja) 2023-04-19
CN115551994A (zh) 2022-12-30
AU2021235252A1 (en) 2022-10-06
US20220235321A1 (en) 2022-07-28

Similar Documents

Publication Publication Date Title
MX2022000893A (es) Metodo de obtencion de mitocondrias de celulas y mitocondrias obtenidas.
ZA202310779B (en) Compositions and methods for enhanced gene expression
AU2016250905A8 (en) Generation of muscle-lineage cells from stem cells
MX2022003477A (es) Medio de cultivo celular complementado con taurina y metodos de uso.
GB2548740A (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
EA201992795A1 (ru) Способ получения эукариотических клеток с отредактированной днк и набор, используемый в этом способе
MY189778A (en) Method for producing retinal pigment epithelial cells
MX2019011778A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
EA201791275A1 (ru) Способы получения ctp-модифицированных полипептидов длительного действия
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
EP3263697A4 (en) Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell
MX2018015298A (es) Metodo para estabilizar proteinas.
PH12019501001A1 (en) Method for preparing electrocompetent yeast cells, and method for using said cells
WO2018101663A3 (ko) 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법
MX2021000153A (es) Dsba y dsbc ultrapurificado y métodos para elaborarlos y utilizarlos.
MX2019011758A (es) Composicion para producir tagatosa y procedimiento de produccion de tagatosa usando la misma.
EP3511410A4 (en) MEDIUM FOR THE CULTURE OF STEM CELLS, METHOD FOR THE CULTURE OF STEM CELLS, STEM CELL GROWTH PROMOTER AND COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF
EP3827027A4 (en) COMPOSITION AND PROCESSES FOR GENERATION AND CONSERVATION OF MOLECULAR HYDROGEN (H2) IN AQUEOUS SYSTEMS
EP4072570A4 (en) METHOD FOR GENERATING HEMATOPOETIC STEM CELLS
MX2021001528A (es) Metodo para la produccion de celulas positivas para cd3.
MX2020003143A (es) Biomaterial que comprende celulas germinales derivadas del tejido adiposo y metodo para su produccion.
EP4039796A4 (en) METHOD FOR PRODUCING COMPOSITION FOR CELL CULTURE, COMPOSITION FOR CELL CULTURE OBTAINED THEREBY, AND CELL CULTURE METHOD USING SAME
SG11201903254PA (en) Undifferentiated stem cell-removing agent, and method for removing undifferentiated stem cells
WO2016005985A3 (en) Method for reprogramming cells
MX2020000366A (es) Métodos biológicos para la modificación de flujo de carbono celular.